Titre : Artériosclérose intracrânienne

Artériosclérose intracrânienne : Questions médicales fréquentes

Termes MeSH sélectionnés :

Hypertriglyceridemia
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Artériosclérose intracrânienne : Questions médicales les plus fréquentes", "headline": "Artériosclérose intracrânienne : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Artériosclérose intracrânienne : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-07-30", "dateModified": "2025-04-26", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Artériosclérose intracrânienne" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Artériopathies intracrâniennes", "url": "https://questionsmedicales.fr/mesh/D020765", "about": { "@type": "MedicalCondition", "name": "Artériopathies intracrâniennes", "code": { "@type": "MedicalCode", "code": "D020765", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C14.907.253.560" } } }, "about": { "@type": "MedicalCondition", "name": "Artériosclérose intracrânienne", "alternateName": "Intracranial Arteriosclerosis", "code": { "@type": "MedicalCode", "code": "D002537", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Daniel Bos", "url": "https://questionsmedicales.fr/author/Daniel%20Bos", "affiliation": { "@type": "Organization", "name": "Department of Epidemiology, Erasmus Medical Center, Rotterdam, CA, The Netherlands." } }, { "@type": "Person", "name": "Meike W Vernooij", "url": "https://questionsmedicales.fr/author/Meike%20W%20Vernooij", "affiliation": { "@type": "Organization", "name": "Department of Epidemiology, Erasmus Medical Center, Rotterdam, CA, The Netherlands." } }, { "@type": "Person", "name": "M Arfan Ikram", "url": "https://questionsmedicales.fr/author/M%20Arfan%20Ikram", "affiliation": { "@type": "Organization", "name": "Department of Epidemiology, Erasmus Medical Center, Rotterdam, CA, The Netherlands." } }, { "@type": "Person", "name": "Tim C van den Beukel", "url": "https://questionsmedicales.fr/author/Tim%20C%20van%20den%20Beukel", "affiliation": { "@type": "Organization", "name": "Department of Epidemiology, Erasmus Medical Center, Rotterdam, CA, The Netherlands." } }, { "@type": "Person", "name": "Frank J Wolters", "url": "https://questionsmedicales.fr/author/Frank%20J%20Wolters", "affiliation": { "@type": "Organization", "name": "Department of Epidemiology, Erasmus Medical Center, Rotterdam, CA, The Netherlands." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Hypertriglyceridemia, a causal risk factor for atherosclerosis, and its laboratory assessment.", "datePublished": "2022-06-10", "url": "https://questionsmedicales.fr/article/35687325", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1515/cclm-2022-0189" } }, { "@type": "ScholarlyArticle", "name": "The nature and characteristics of hypertriglyceridemia in a large cohort with type 2 diabetes.", "datePublished": "2022-12-28", "url": "https://questionsmedicales.fr/article/36669323", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.jdiacomp.2022.108387" } }, { "@type": "ScholarlyArticle", "name": "Bioactive oxylipins in type 2 diabetes mellitus patients with and without hypertriglyceridemia.", "datePublished": "2023-08-17", "url": "https://questionsmedicales.fr/article/37664847", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3389/fendo.2023.1195247" } }, { "@type": "ScholarlyArticle", "name": "Efficacy and safety of pemafibrate in patients with hypertriglyceridemia in clinical settings: A retrospective study.", "datePublished": "2023-02-21", "url": "https://questionsmedicales.fr/article/37246074", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.numecd.2023.02.011" } }, { "@type": "ScholarlyArticle", "name": "Liver enzymes mediate the association between aldehydes co-exposure and hypertriglyceridemia.", "datePublished": "2023-08-12", "url": "https://questionsmedicales.fr/article/37579588", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.ecoenv.2023.115346" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Maladies cardiovasculaires", "item": "https://questionsmedicales.fr/mesh/D002318" }, { "@type": "ListItem", "position": 3, "name": "Maladies vasculaires", "item": "https://questionsmedicales.fr/mesh/D014652" }, { "@type": "ListItem", "position": 4, "name": "Angiopathies intracrâniennes", "item": "https://questionsmedicales.fr/mesh/D002561" }, { "@type": "ListItem", "position": 5, "name": "Artériopathies intracrâniennes", "item": "https://questionsmedicales.fr/mesh/D020765" }, { "@type": "ListItem", "position": 6, "name": "Artériosclérose intracrânienne", "item": "https://questionsmedicales.fr/mesh/D002537" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Artériosclérose intracrânienne - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Artériosclérose intracrânienne", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-02", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Artériosclérose intracrânienne", "description": "Comment diagnostiquer l'artériosclérose intracrânienne ?\nQuels tests sont utilisés pour évaluer la circulation cérébrale ?\nQuels signes cliniques indiquent une artériosclérose intracrânienne ?\nL'évaluation neurologique est-elle nécessaire ?\nPeut-on utiliser des biomarqueurs pour le diagnostic ?", "url": "https://questionsmedicales.fr/mesh/D002537?mesh_terms=Hypertriglyceridemia&page=3#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Artériosclérose intracrânienne", "description": "Quels sont les symptômes courants de l'artériosclérose intracrânienne ?\nL'artériosclérose intracrânienne cause-t-elle des AVC ?\nPeut-on avoir des symptômes sans douleur ?\nLes troubles cognitifs sont-ils fréquents ?\nLes symptômes varient-ils selon l'âge ?", "url": "https://questionsmedicales.fr/mesh/D002537?mesh_terms=Hypertriglyceridemia&page=3#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Artériosclérose intracrânienne", "description": "Comment prévenir l'artériosclérose intracrânienne ?\nLe contrôle de la pression artérielle est-il important ?\nLe tabagisme influence-t-il le risque ?\nL'exercice régulier aide-t-il à prévenir la maladie ?\nLes examens médicaux réguliers sont-ils nécessaires ?", "url": "https://questionsmedicales.fr/mesh/D002537?mesh_terms=Hypertriglyceridemia&page=3#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Artériosclérose intracrânienne", "description": "Quels traitements sont disponibles pour l'artériosclérose intracrânienne ?\nLes anticoagulants sont-ils utilisés ?\nLa rééducation est-elle nécessaire après un AVC ?\nLes changements de mode de vie sont-ils recommandés ?\nDes interventions chirurgicales sont-elles possibles ?", "url": "https://questionsmedicales.fr/mesh/D002537?mesh_terms=Hypertriglyceridemia&page=3#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Artériosclérose intracrânienne", "description": "Quelles complications peuvent survenir ?\nL'artériosclérose intracrânienne peut-elle entraîner des crises ?\nLes troubles de la mémoire sont-ils une complication ?\nPeut-on avoir des troubles de l'équilibre ?\nLes complications sont-elles réversibles ?", "url": "https://questionsmedicales.fr/mesh/D002537?mesh_terms=Hypertriglyceridemia&page=3#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Artériosclérose intracrânienne", "description": "Quels sont les principaux facteurs de risque ?\nL'âge est-il un facteur de risque ?\nLe cholestérol élevé influence-t-il le risque ?\nLe stress a-t-il un impact sur le risque ?\nLes antécédents familiaux jouent-ils un rôle ?", "url": "https://questionsmedicales.fr/mesh/D002537?mesh_terms=Hypertriglyceridemia&page=3#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer l'artériosclérose intracrânienne ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Le diagnostic repose sur l'imagerie cérébrale, comme l'IRM ou le scanner." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour évaluer la circulation cérébrale ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des tests comme l'angiographie cérébrale et l'échographie Doppler sont utilisés." } }, { "@type": "Question", "name": "Quels signes cliniques indiquent une artériosclérose intracrânienne ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Des signes comme des maux de tête persistants et des troubles neurologiques peuvent indiquer la maladie." } }, { "@type": "Question", "name": "L'évaluation neurologique est-elle nécessaire ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une évaluation neurologique complète est essentielle pour le diagnostic." } }, { "@type": "Question", "name": "Peut-on utiliser des biomarqueurs pour le diagnostic ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Actuellement, il n'existe pas de biomarqueurs spécifiques pour cette condition." } }, { "@type": "Question", "name": "Quels sont les symptômes courants de l'artériosclérose intracrânienne ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent des maux de tête, des vertiges et des troubles de la vision." } }, { "@type": "Question", "name": "L'artériosclérose intracrânienne cause-t-elle des AVC ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elle peut augmenter le risque d'accidents vasculaires cérébraux." } }, { "@type": "Question", "name": "Peut-on avoir des symptômes sans douleur ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certains patients peuvent présenter des symptômes neurologiques sans douleur." } }, { "@type": "Question", "name": "Les troubles cognitifs sont-ils fréquents ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des troubles cognitifs peuvent survenir en raison de la réduction du flux sanguin." } }, { "@type": "Question", "name": "Les symptômes varient-ils selon l'âge ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les symptômes peuvent varier en fonction de l'âge et de la gravité de la maladie." } }, { "@type": "Question", "name": "Comment prévenir l'artériosclérose intracrânienne ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "La prévention passe par un mode de vie sain, incluant une alimentation équilibrée et de l'exercice." } }, { "@type": "Question", "name": "Le contrôle de la pression artérielle est-il important ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, maintenir une pression artérielle normale est crucial pour prévenir la maladie." } }, { "@type": "Question", "name": "Le tabagisme influence-t-il le risque ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le tabagisme augmente le risque d'artériosclérose intracrânienne." } }, { "@type": "Question", "name": "L'exercice régulier aide-t-il à prévenir la maladie ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'exercice régulier contribue à la santé cardiovasculaire et à la prévention." } }, { "@type": "Question", "name": "Les examens médicaux réguliers sont-ils nécessaires ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des examens réguliers aident à détecter les problèmes précocement." } }, { "@type": "Question", "name": "Quels traitements sont disponibles pour l'artériosclérose intracrânienne ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Les traitements incluent des médicaments pour contrôler la pression artérielle et des interventions chirurgicales." } }, { "@type": "Question", "name": "Les anticoagulants sont-ils utilisés ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les anticoagulants peuvent être prescrits pour prévenir les caillots sanguins." } }, { "@type": "Question", "name": "La rééducation est-elle nécessaire après un AVC ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Oui, la rééducation est souvent nécessaire pour récupérer des fonctions perdues." } }, { "@type": "Question", "name": "Les changements de mode de vie sont-ils recommandés ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des changements comme une alimentation saine et l'exercice sont recommandés." } }, { "@type": "Question", "name": "Des interventions chirurgicales sont-elles possibles ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des interventions comme le pontage ou l'angioplastie peuvent être envisagées." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Les complications incluent les AVC, les démences et les troubles cognitifs." } }, { "@type": "Question", "name": "L'artériosclérose intracrânienne peut-elle entraîner des crises ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elle peut augmenter le risque de crises épileptiques chez certains patients." } }, { "@type": "Question", "name": "Les troubles de la mémoire sont-ils une complication ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des troubles de la mémoire peuvent survenir en raison de la réduction du flux sanguin." } }, { "@type": "Question", "name": "Peut-on avoir des troubles de l'équilibre ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des troubles de l'équilibre peuvent être une complication de cette maladie." } }, { "@type": "Question", "name": "Les complications sont-elles réversibles ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Certaines complications peuvent être réversibles avec un traitement approprié." } }, { "@type": "Question", "name": "Quels sont les principaux facteurs de risque ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les facteurs incluent l'hypertension, le diabète, le tabagisme et l'obésité." } }, { "@type": "Question", "name": "L'âge est-il un facteur de risque ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le risque d'artériosclérose augmente avec l'âge." } }, { "@type": "Question", "name": "Le cholestérol élevé influence-t-il le risque ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, un taux de cholestérol élevé est un facteur de risque significatif." } }, { "@type": "Question", "name": "Le stress a-t-il un impact sur le risque ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le stress chronique peut contribuer à l'augmentation du risque." } }, { "@type": "Question", "name": "Les antécédents familiaux jouent-ils un rôle ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des antécédents familiaux d'artériosclérose augmentent le risque." } } ] } ] }

Sources (397 au total)

The nature and characteristics of hypertriglyceridemia in a large cohort with type 2 diabetes.

To determine the prevalence of mild, moderate and severe hypertriglyceridemia (HTG) in a large, diverse healthcare system cohort with type 2 diabetes (T2D) and to study associations between triglyceri... 19,086 individuals with T2D were studied between 2015 and 2020. We compared groups with normotriglyceridemia (<150 mg/dl [<1.7 mmol/l]), mild (150-199 mg/dl [1.7-2.25 mmol/l]), moderate (200-499 mg/dl... 39 % had triglyceride levels ≥150 mg/dl (<1.7 mmol/l), 19 % had moderate and 2 % had severe HTG. There was a lower proportion of Blacks in all HTG categories compared to Whites. There was no overall g... This study fills gaps in our knowledge of the distribution and clinical associations of HTG in T2D and characterizes the features of the small but important group with severe HTG. We demonstrate the i...

Bioactive oxylipins in type 2 diabetes mellitus patients with and without hypertriglyceridemia.

Dyslipidemia, in particular elevated triglycerides (TGs) contribute to increased cardiovascular risk in type 2 diabetes mellitus (T2DM). In this pilot study we aimed to assess how increased TGs affect... 40 patients with T2DM were characterized analyzing routine lipid blood parameters, as well as medical history and clinical characteristics. Patients were divided into a hypertriglyceridemia (HTG) grou... Mean value of hepatic fat content measured as CAP as well as body mass index (BMI) were significantly higher in patients with high TGs as compared to those with normal TGs, and correlation analysis sh... In adult patients with T2DM, elevated TGs were associated with increased liver fat and BMI. Furthermore, these patients also had significantly higher plasma levels of CYP- and LOX- oxylipins, which co...

Efficacy and safety of pemafibrate in patients with hypertriglyceridemia in clinical settings: A retrospective study.

Recently, pemafibrate, a selective PPARα modulator, has been developed as a treatment for hypertriglyceridemia and has attracted much attention. The aims of this study were to evaluate the efficacy an... We evaluated changes in lipid profiles and various parameters before and after 24-week pemafibrate administration in patients with hypertriglyceridemia who had not previously taken fibrate medications... In this study, pemafibrate improved the metabolism of atherosclerosis-induced lipoproteins in hypertriglyceridemia patients. In addition, it showed no off-target effects such as hepatic and renal dama...

Tocilizumab-related hypertriglyceridemia is independent of key molecules regulating lipid metabolism.

Tocilizumab (TCZ) treatment is associated with dyslipidaemia, including a rise in triglycerides through a mechanism poorly understood. Three molecules play key roles in the regulation of triglyceride ... Twenty-seven RA patients included in the TOCRIVAR study who received TCZ (8 mg/kg IV/q4w) were evaluated at baseline and at Weeks 12, 24 and 52 of treatment. ANGPTL4, ApoC-III and LPL, a complete lipi... After 24 weeks of TCZ treatment, HDL cholesterol, apolipoprotein A1 and triglycerides increased, whereas lipoprotein (a) decreased significantly from baseline values. However, 1 year after TCZ, no sig... In TCZ-treated RA patients basal serum levels of ANGPLT4 and ApoC-III, but not LPL, decreased significantly. However, the elevation of triglycerides after TCZ was not related to changes in these regul...

A protocol for an international, multicenter, prospective, non-interventional observational registry for patients with hypertriglyceridemia.

In the study on triglyceride-induced pancreatitis (TG-IAP), a core clinical dataset using the Jandhyala method was developed to collect the minimum amount of information for each patient presenting wi... The study is designed as an international, multicenter, non-interventional, observational registry that will enroll adult patients with hypertriglyceridemia to collect natural history data on the trea... Data from this registry, and others like it, is intended for healthcare providers to optimize clinical decision-making through an enhanced understanding of the variability, progression, and natural hi... Global epidemiological data on hypertriglyceridemia and its role in acute pancreatitis is limited. Using real-world evidence, this registry, along with others like it, may help healthcare providers un...

Hypertriglyceridemia as a risk factor for complications of acute pancreatitis and the development of a severity prediction model.

Hypertriglyceridemia (HTG) is a major cause of acute pancreatitis (AP). We aimed to determine whether HTG is an independent risk factor for AP complications and construct a prediction model for non-mi... We conducted a multi-center cohort study including 872 patients with AP and divided them into HTG-AP and non-HTG-AP groups. Multivariate logistic regression was performed, and a prediction model for n... HTG-AP patients had a higher risk of systemic complications, including systemic inflammatory response syndrome [odds ratio (OR): 1.718; 95% confidence interval (CI): 1.286-2.295], shock (OR: 2.103; 95... HTG is an independent risk factor for AP complications. We constructed a simple and accurate prediction model for progression of non-mild AP....